The Venture Codex Logo

The Venture Codex

Cystic Fibrosis Foundation

4550 Montgomery Ave. Suite 1100 N, Bethesda, MD, 20814, United States

Overview

Funding research and promoting care for cystic fibrosis.

Founded

1955

Deals ยท 12mo

2

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B

Geographic focus

Israel
United Kingdom
United States

Sector focus

Association
Non Profit

Investment portfolio

28rounds
NAMEDATESIZE
Ride Therapeutics
Sep 2026Led
$7 MOther Equity
Splisense
Jun 2026Led
$13 MOther Equity
SNIPR Biome
Aug 2025Participated
$41 MSeries B
Prime Medicine
Jul 2025Led
$24 MOther Equity
ReCode Therapeutics
Nov 2024Led
$15 MOther Equity
Splisense
Apr 2024Led
$9 MOther Equity
Sionna Therapeutics
Mar 2024Participated
$182 MSeries C
Prime Medicine
Jan 2024Led
$15 MOther Equity
Clarametyx Biosciences
Jan 2024Participated
$33 MSeries A
ViaNautis
Nov 2023Participated
$25 MSeries A
Arcturus Therapeutics
Sep 2023Led
$9 MOther Equity
Anagram Therapeutics
Apr 2023Led
$16 MOther Equity
Ride Therapeutics
Sep 2026Led
$7 MOther Equity
Splisense
Jun 2026Led
$13 MOther Equity
SNIPR Biome
Aug 2025Participated
$41 MSeries B
Prime Medicine
Jul 2025Led
$24 MOther Equity
ReCode Therapeutics
Nov 2024Led
$15 MOther Equity
Splisense
Apr 2024Led
$9 MOther Equity
Sionna Therapeutics
Mar 2024Participated
$182 MSeries C
Prime Medicine
Jan 2024Led
$15 MOther Equity
Clarametyx Biosciences
Jan 2024Participated
$33 MSeries A
ViaNautis
Nov 2023Participated
$25 MSeries A
Arcturus Therapeutics
Sep 2023Led
$9 MOther Equity
Anagram Therapeutics
Apr 2023Led
$16 MOther Equity
28
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cystic Fibrosis Foundation: 28 funding rounds are recorded in the selected participation categories.All available history.
Cystic Fibrosis Foundation: 28 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A03
Series B23
Series C+04
Other Equity151

Monthly Deal Activity

Cystic Fibrosis Foundation: 28 deals are recorded across 137 months.All available history.
Cystic Fibrosis Foundation: 28 deals are recorded across 137 months. All available history
MonthDeals
Jun '151
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '171
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '191
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '191
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '200
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '212
Jan '221
Feb '220
Mar '221
Apr '221
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '221
Jan '231
Feb '230
Mar '231
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '231
Dec '230
Jan '242
Feb '240
Mar '241
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '251
Aug '251
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Cystic Fibrosis Foundation: Health & Life Sciences is the largest displayed sector by deal count (28 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cystic Fibrosis Foundation: Health & Life Sciences is the largest displayed sector by deal count (28 deals). All available history
SectorDeals
Health & Life Sciences28
AI & Machine Learning2
Space & Frontier Tech1
Consumer & Lifestyle1

Deal Size Distribution

Cystic Fibrosis Foundation: 28 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cystic Fibrosis Foundation: 28 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M4
$10M-$25M9
$25M-$50M5
$50M-$100M2
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cystic Fibrosis Foundation: United States has the largest recorded deal count among the displayed regions (20 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Cystic Fibrosis Foundation: United States has the largest recorded deal count among the displayed regions (20 deals). All available history
RegionDeals
United States20
Europe5
Israel3
Cystic Fibrosis Foundation: 20 co-investors are shown, with T. Rowe Price Associates sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cystic Fibrosis Foundation: 20 co-investors are shown, with T. Rowe Price Associates sharing 3 recorded deals. All available history
Co-investorShared deals
T. Rowe Price Associates3
Atlas Venture2
Longwood Fund2
OrbiMed2
Perceptive Advisors2
Q Healthcare Holdings2
RA Capital Management2
TPG2
Viking Global Investors2
17761
4BIO Capital1
Adjuvant Capital1
Agent Capital1
Amzak Health1
ArrowMark Partners1
Asahi Kasei Pharma1
Astellas Venture Management1
Berkeley Catalyst Fund1
BGF1
BVF Partners1

Investment Strategy

Cystic Fibrosis Foundation: Led accounts for 61% and participating for 39% of round participation.All available history.
Cystic Fibrosis Foundation: Led accounts for 61% and participating for 39% of round participation. All available history
CategoryDeals (count)Share (%)
Led1761%
Participating1139%
Cystic Fibrosis Foundation: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Cystic Fibrosis Foundation: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead17100%
Co-led00%

Team

Amber Walters

Development Director

Clancy JP

Vice President of Clinical Research at Cystic Fibrosis

Dominic J. Caruso

Member of the Board of Directors

Kathryn Brown

Chief Communications and Marketing Officer

Mike Thompson

Member, Board of Directors

Preston Campbell

Executive Vice President for Medical Affairs

Tim Olsen

Member Board Of Directors- MN Dakota Chapters

Wynne Sharples

Founder